NCT02271425View on ClinicalTrials.gov

A Study to Measure the Amount of Evacetrapib That Enters the Blood Stream in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions
Healthy Volunteers
Interventions
DRUG

Evacetrapib Tablet

Oral administration

DRUG

Evacetrapib Intravenous

Intravenous administration

Trial Locations (1)

LS2 9LH

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Leeds

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT02271425 - A Study to Measure the Amount of Evacetrapib That Enters the Blood Stream in Healthy Participants | Biotech Hunter | Biotech Hunter